Glaxo buys Canadian cough drug maker for $2 bn

by

British drugmaker GlaxoSmithKline on Tuesday announced the purchase of Canadian chronic cough treatment specialist Bellus for US$2 billion.

Leave A Comment

Your email address will not be published. Required fields are marked *